PWS
AZN icon

Precision Wealth Strategies’s AstraZeneca AZN Stock Holding History

Precision Wealth Strategies’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Sell
1,104
-75
-6% -$14.1K 0.06% 164
2026
Q1 		$233K Sell
1,179
-9
-0.8% -$1.74K 0.08% 150
2025
Q4 		$218K Buy
+1,188
New +$208K 0.07% 152

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Precision Wealth Strategies's AZN Position: Q2 2026 in Review

Precision Wealth Strategies reduced its AstraZeneca (AZN) stake by 6.4% in Q2 2026, selling an estimated $14.1K and leaving 1,104 shares worth $209K. The position accounts for 0.06% of the portfolio, ranked #164.

Precision Wealth Strategies first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $233K in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Precision Wealth Strategies held 1,104 shares of AstraZeneca worth $209K as of Q2 2026.
  • Precision Wealth Strategies sold 75 AstraZeneca shares in Q2 2026, an estimated $14.1K.
  • AstraZeneca made up 0.06% of Precision Wealth Strategies's portfolio in Q2 2026, its #164 holding.
  • Precision Wealth Strategies first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • Precision Wealth Strategies's AstraZeneca position peaked at $233K in Q1 2026.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Precision Wealth Strategies's 13F filing for Q2 2026, filed 10 Aug 2026.